Purpose: Familial clustering of abdominal aortic aneurysm was first noticed in 1977. Methods: Through questionnaire and phone inquiry, familial data on 324 probands with abdominal aortic aneurysms allowed the establishment of 313 multigenerational pedigrees including 39 with multiple affected patients.
natural history of the disease, the pathogenesis and the genetic background remain obscure. Each mode of inheritance (dominant, recessive, X-linked, multifactorial) was advocated in turn.
Most studies of common diseases assume that genetically determined factors are numerous and give an equal and individually small contribution to the phenotype (polygenic models), hence limiting the possibility of formal genetic analysis to the computation of heritability. The question of whether a single identifiable locus accounts for a significant amount of the phenotypic variation in a population may be addressed through the methods of segregation analysis.
In this article we present the results of a pedigree analysis of more than 300 probands with classical epidemiologic and statistical tools. We explored the mixed model of Morton and McLean 6 as modified by Lalouel and Morton. 7 Definition of AAA. A consensus definition of AAA does not exist. Depending on authors, minimal infrarenal aortic diameter varies from 30 mm to 40 mm, and the minimal ratio infrarenal diameter/suprarenal diameter varies from 1.5 : 1 to 2 : 1. We considered a patient to be affected, if he or she had a dilatation of the infraaortic aorta higher than 30 mm or a ratio infrarenal diameter/suprarenal diameter higher than 1.5 : 1.
MATERIAL
Between 1986 and 1991, 520 patients (489 men and 31 women) were surgically treated in our department for asymptomatic AAA or symptomatic (ruptured or not) nonsyndromal AAA. We excluded from this series the patients with Marfan syndrome (all of them with thoraco-abdominal aneurysms) or with Ehlers-Danlos syndrome. No systematic ultrasound screening was performed or even recommended for the siblings of the patients during the study period. We sent a written questionnaire oriented to personal and familial history to the 520 patients irrespective of any familial or surgical particularity. The questionnaire included names, birth date, address or phone number, and history of vascular problem in parents, siblings, and children of the probands. The patients who filled out the questionnaire (or their spouses, for deceased probands) were interviewed by the phone, and relatives were then contacted in the same way to obtain the most accurate and best cross-validated pedigrees. Anamnestic data were compared with surgical files. Because only a fraction of the affected patients from our referring population were enrolled in this study, and because some families were ascertained more than once, the ascertainment mode was multiple and incomplete.
METHODS
Descriptive statistics. Descriptive statistics were performed with classical methods. Comparison of proportions was done by the chi-squared test (with Yates' correction when sample was small), and comparison of means was done by unpaired t test.
Relative risks. Relative risks were estimated by the ratio between the observed number and the expected number of AAA in the nonproband subjects for each age class, and confidence interval for the risk was computed by the method suggested by Everitt. 8 We used a slightly edited version of the cumulative age incidence published by Majumder et al.9; our version was based on the AAA survey of Bickerstaff et al.~ The modification was to set the incidence to 0 for men younger than 30 years (Table I) .
Survival functions. Survival functions were computed by the classical Kaplan-Meier product limit. This method estimates the survival function from the continuous survival or failure times. It allows the computation of survival curves when a proportion of the studied patients "fails" (either because they are lost to follow-up or because the experiment stops before they are affected). Relatives alive at time of study or dead without evidence of AAA were Segregation analysis. Segregation analysis is basically the comparison of the observed proportion of affected siblings and offspring with the expected proportion according to a particular genetic hypothesis. To assess evidence of a major gene effect in the presence of other sources of correlation (polygene, sociocultural factors, etc.), pedigrees were analyzed with the pointer strategy, which was developed by Lalouel and Morton 7 as a tool for multigenerational pedigrees analysis.
Coding of the pedigrees. Pedigrees were partitioned in nuclear families. A nuclear family-the unit of analysis-is made of the two parents and their children. Three types of nuclear families differing by the ascertainment mode were enrolled: families where the proband was a child (multiple incomplete selection of proband's siblings), families where the proband was one of the parents (complete selection of proband's children), and families where none of the affected patients was a proband (truncated selection of the siblings). In the latter case "pointers" had to be added to the nuclear family. A pointer is an affected individual outside the nuclear family who contributed to the selection of this family. A maximum of three pointers is allowed, one to the father, one to the mother, and one to the children. Each pointer is defined by the relationship to the pointee (cousin, nephew, etc.). ?p < 0.001. Sp < 0.001. Age statistics are given based on censoring age or age at death for unaffected subjects and age at diagnosis for patients with AAA. The study was reiterated with multiplex pedigrees only. This selection, limited to familial cases, biased the sample. Accordingly a sampling correction was applied to families with two affected siblings by defining the proband as a pointer (with a "sibling" degree of relationship), whereas his or her siblings were treated by truncated selection) ° Ascertainment probability. Ascertainment of our pedigree was multiple (some pedigrees had more than one proband) and incomplete. Ascertainment probabilityp is the probability that an affected person in the population is a proband. In our sample p was 0.248 as calculated by a multiple ascertained sibling method and was 0.2 to 0.4 as estimated by the comparison of the number of annual AAA operated with the expected number of cases in the Liege area; an incidence of 4 per 100,000 per year was assumed. A value of 0.25 was used for all computations. Analysis was limited to the mixed model. It assumes that a phenotype (expressed as a discrete or continuous value) results from the independent and additive contributions of three effects on a liability scale measured in SD units: a major monogenic biallelic effect, a multifactorial (genetic or acquired) transmissible effect, and a normally distributed residual. Variation of the phenotype for each major genotype is assumed to be normally distributed. Its variance is the sum of two components: a part resulting from the multifactorial component and an unexplained residual environmental variance. Note that heritability H represents the ratio of the multifactorial component of the variance to the total phenotypic variance. Two parameters define the phenotype: the overall variance V (set to 1 for qualitative traits) and the overall mean u (set to 0 for qualitative traits). The polygenic component has two parameters, the polygenic heritability in children H and the parent-to-child heritability ratio Z. The parameter of the monogenic component is formed by the frequency of the pathologic allele at the major locus q, the distance, or displacement, between the two homozygous genotype means on the liability scale t, and the position d of the heterozygous mean relative to the two homozygous means (equal to 0, 1, or 0.5 for a recessive, a dominant, or a codominant pathologic allele, respectively), and three transmission probabilities %, %, and %, which are the probabilities for a subject of genotype AA, Aa, or aa, respectively, to transmit the allele A. Under the mixed model, which assumes mendelian inheritance of the major effect, % = 1, % = 0.5 and % = 0.
Computation and statistical tests. Parameters ofthe model were estimated by POINTER by maximization of the likelihood of the phenotypes of the siblings conditional on the phenotype of the parents and the pointers. Competing nested models were built by fixing some parameters. Nested models were compared by likelihood ratio test. The difference between -2 In (likelihood) is asymptomatically distributed as a chi-squared analysis with the degrees of freedom equal to the difference in the number of estimated parameters. Nonncsted models were compared by the Akaike information criterion, which is two times the number of estimated parameters -2 In (likelihood). The best model has the smallest Akaike information criterion.
RESULTS
Questionnaire. We obtained answers for 324 patients (62% of our original sample), allowing a two-or three-generational pedigree to be drawn. Four questionnaires were filled out by the spouses of deceased patients. Those 324 probands (312 men and 12 women, sex ratio 26 : 1) came from 313 large pedigrees. The sex ratio of our original sample of 520 patients with AAA was 15.7: 1. The higher mean age (at operation) in the women in the original sample compared with that of the men (74.07 _+ 9.04 vs 68.2 + 7.9 years) could be a reason for their reduced answer rate compared with that of the men and a rise of the sex ratio. Whenever possible relatives of the proband (usually siblings), including all relatives suspected to have a vascular problem, were interviewed by phone. The questionnaire appeared to be a very reliable tool for familial enquiry, because only minor discrepancies were found by this crossreferencing procedure except for some confusion between correction of AAA and aortofemoral bypass. Because of the rarity of aneurysms in young people, we excluded the relatives younger than 30 years from the study.
Descriptive statistics of the sample. The total number of patients with AAA in our 313 large pedigrees was 357 (340 men and 17 women, sex ratio 20 : 1). For 276 probands (264 men and 12 women, sex ratio 22:1) no positive familial history was elected, but 68 male patients belonged to 39 multiplex pedigrees (12.5%). In the latter families 33 new patients with AAA were found (28 men and 5 women), leading to a total of 81 patients with familial AAA: 76 men and five women (sex ratio 15:1).
Based on 313 large pedigrees we constructed 582 nuclear families including 2695 subjects aged 30 years or older. Those nuclear pedigrees were used for segregation analysis.
In the familial group all affected women were found among the parents of the probands. Among familial cases 23 pedigrees showed affected siblings and healthy parents, 10 showed an affected parent and an affected child, and six showed more complex structures (affected cousins, uncle, and nephew, etc.). The sex ratio was not significantly different among familial and sporadic subgroups (Yates corrected chi-squared analysis = 0.06,p = 0.80). In six families' patients with cerebral aneurysms were observed. Because aneurysms in the central nervous system are hard to dismiss among patients with "sudden death," we did not take those cases into account for the analysis.
To avoid duplicate use of subjects (a case being a parent in one nuclear pedigree and a child in another) the descriptive analysis of the pedigree was limited to the 315 nuclear families in which the probands appeared as children. Those nuclear pedigrees included 630 parents and 967 children. The 1597 subjects were 965 men and 632 women. After one proband was removed, the sex ratio of our sample was close to 1 : 1 (625 men and 615 women). Table II presents the numeric data regarding the patients with AAA and their unaffected relatives. They are partitioned in two groups: simplex and multiplex pedigrees. No significant differences in age were seen between patients with and without AAA. The age at diagnosis was significantly different among affected brothers of the two groups (t test = 2.50,p = 0.013) and also among affected fathers and affected children in the familial subgroup (t test = 3.15, p = 0.002). The latter phenomenon was attributed either to a true "anticipation" of the diagnosis resulting from better medical awareness or to the use of more accurate and advanced methods for diagnosing AAA during the last 10 years. Another hypothesis was that nonrecording or bad diagnosis of some early cases (in the 1950s) led to an undue rise of the mean age at diagnosis. Finally, this phenomenon could reflect the natural increase in age-specific prevalence of this condition.IS The rupture ratio was much higher in the familial subgroup than in the sporadic one (chi-squared analysis = 23, p < 0.0001). The mean rupture age was significantly different among affected brothers of the two groups (p < 0.001). In the familial group the proportion of rupture in men and women was not significantly different (chi-squared analysis = 0.71, p = 0.040).
Relative risk by sex We used only the group of brothers for this analysis. Occurrence in the siblings (after removal of one proband per sibling relationship) was compared with the expected recurrence assuming random occurrence of AAA. Table III shows the relative risk by age groups. The overall relative risk was 17.9 (95% confidence interval 12.9 to 22.9). Relative risk appeared to be major in the 50 to 59-year-old subgroup and declined for elder subgroups but with very wide confidence intervals so that no definite conclusion could be drawn.
Survival curves The Kaplan-Meier method was used on several subpopulations of our sample. Fig. 1 shows the survivorship function obtained with the 967 siblings (including 357 patients with AAA) coming from our nuclear pedigrees. To compare effects of sex and of positive familial history, several subgroups of siblings were extracted: men of the multiplex pedigrees, male probands and nonprobands of the multiplex pedigrees, male siblings of the sporadic pedigrees, and women of the sporadic pedigrees. To test whether the differences between the survivorship function reached statistical significance, we applied both Cox-Mantel and Gehan's Wilcoxon tests to the survivorship curves (Table  IV, A) . A highly significant difference was seen between men and women with sporadic AAA. Male siblings of multiplex pedigrees were affected significantly earlier than male siblings in the sporadic pedigrees. A significant difference was seen between the two groups of men; a more rapid decrease was seen in the survival curve of the familial subgroup (Gehan's Wilcoxon test: 3.6, p = 0.00016; CoxMantel test: 3.23, p = 0.00061) (Fig. 2) . This difference was no longer observed when the sibs of sporadic cases were compared with the sibs of familial cases after the probands were removed. This finding indicates a possible bias to the earlier diagnosis of AAA in the familial cases. To further explore this phenomenon we compared male probands; a clear difference persists, although of borderline significance, when male probands of the multiplex pedigrees are compared with male probands with sporadic pedigrees. Finally, a significant difference appeared to exist between affected probands and affected nonprobands in the familial group (Table  IV, B) .
Segregation analysis. The 582 nuclear families were analyzed with POINTER. Of those families 101 belonged to the multiplex pedigrees. They were studied separately after recoding. Eight models (sporadic, multifactorial, polygenic, dominant, recessive, codominant, mixed, and mendelian) were evaluated.
The results of the analysis of the full sample are given in Table V , A. The subset of pedigrees with a positive familial history is shown in Table V, B. Comparison of the models was done as follows. The sporadic model of Table V , A has a -2InL parameter of 637.23 and the dominant model a -21nL of 503.25. The difference (133.98) as calculated by chi-squared analysis with 3 degrees of freedom was highly significant, indicating that the dominant model is significantly more likely. When the chisquared test is not significant, the best of the two models is the model with the lesser free parameters (the most parsimonious one). When two models have the same degree of freedom (as in comparison of the dominant, recessive, or codominant models), the smaller Akaike criterion indicates the best model.
Analysis of the full set shows that a sporadic model is strongly rejected. When a purely mendelian inheritance of AAA is assumed, the best fit is obtained with a dominant model even when the dominance parameter is set free. No significantly better fit is obtained for a mixed model when a combined effect of dominantly inherited mutation and a weak multifactorial component is assumed, although this situation gives the best likelihood. The analysis of the familial subgroup shows almost similar results; the mixed model does not give a significantly better fit than a purely monogenic model with dominant inheritance (Table V, B) .
The most parsimonious way to explain the segregation of AAA in our multiplex pedigrees is to suspect the action of a single dominant genc, for which the frequency of the morbid allele is 1 : 250 and in which the sex-dependent penetrance slowly increases with age to reach a maximum of 0.3 in women 16 .2% of familial AAA history based on anamnesis in 43 consecutive patients with AAA. After prospective ultrasonography screening of the relatives, the number of familial cases was raised to 27.9%. In male siblings of patients with AAA, Bengtsson et al. zz found 29% of AAA after ultrasonography screening.
Genetic aspects. Genetic aspects of AAA have been the subject of very few studies. Norrgard et al.15 presented 19 patients (18% of their sample) with familial AAA but did not discuss etiology. Tilson and Seashore 2° showed 50 families including three pairs of identical twins. Those families were collected by various teams, and no data were given on the mode of ascertainment or on the isolated AAA from the same population. Twenty-nine of 50 were singlegenerational, 18 showed simple "vertical" transmission, and three were "complex." In an empiric approach of the results they favored a frequent X-linked dominant form and a less common autosomal/dominant or a multifactorial model. They excluded recessive inheritance because of the high frequency of parent-to-sibling transmission and questioned the shift of the sex ratio. Assuming that AAA is a multifactorial disease, Powell and Greenhalgh 14 calculated for a series of 60 patients (25 with positive family history) a 70% heritability by the method of Falconer. 23 In their set, eleven (8.6%) of 128 parents and 14 (7.3%) of 192 siblings of the probands had AAA. Separate heritabilities were not computed for those two subsets. Recently Majumder et al. 9 made an extensive segregation analysis based on 91 probands including 13 familial cases (10 singlegenerational). The mode of selection of the families was not reported, but systematic screening was not used. They concluded that susceptibility to AAA can be accounted for by the presence of a major gene, that it does not require a multifactorial component, and that this gene behaves as a recessive factor.
Our results, like those of Majumder et al. 9 indicate that the importance of the genetic factor in the pathogenesis of AAA compared with the multifactorial or environmental effects. Nevertheless our final conclusions are in disagreement. Several factors may explain this discrepancy. Our population differs by the sex ratio. The ascertainment of our sample is quite different. The mode of selection of Majumder et al.'s patients 9 was not clear. The number of familial cases was very small, and their sample could have included, by chance, fewer pedigrees with subjects affected in two generations. Moreover their methods were also different. The definition of AAA was an aortic diameter greater than 5 cm; we used a less stringent definition. Majumder ct al.9 counted as "affected" only patients with operated AAA and used age at operation for analysis. They rejected patients who were discovered by systematic screening, whereas we considered all patients with known AAA, whatever the reason for their discovery (although we had no policy of systematic screening before 1992). It should be noted that the patients with AAA included in the study by Bickerstaffet al. 1 to compute incidences were gathered from all sources including diagnosis "by chance" and necroscopic discovery of patients not thought to have AAA. Although it is difficult to ascertain whether those differences account for the diverging conclusions, they at least indicate that our studies are not totally comparable in their methods. Our sample shows a sex ratio much higher than that of other reported series. We have no definite explanation for this phenomenon. An excess of men could come from our ascertainment of cases; male subjects are more exposed to coronary problems or atheromatosis and so have a much greater chance to be diagnosed "by chance." The sex ratio of AAA varies with the age group; the ratio is higher in younger persons. If the population attending our hospital has a lower mean age compared with other institutions, we could expect a higher sex ratio. Finally, we cannot exclude genetic, sociocultural, or environmental effects, although these are not obvious.
Familial cases show a significantly earlier onset as observed by Darling et al.17 Higher rupture rate also characterizes our familial sample. Various explanations for earlier diagnosis such as familial awareness of the risk may be hypothesized. But because penctrance of the gene appears age-dependent, we may suspect that intrinsic factors affecting penetrance may influence expressivity, for example, more pathogenic mutations of the putative AAA gene are more likely to be expressed earlier in several relatives and to lead them more rapidly to an aneurysmal rupture.
Kontusaari et al. 24 showed two single-base mutations in the type III procollagen gene in two families with AAA. In the first multigenerational family the mutation led to the replacement of glycine 619 by arginine. In the second two-generational family, which presented with AAA and easy bruisability, the single-base mutation G -> A in intron 20 was shown to induce aberrant splicing of the mRNA that reduces the synthesis of the cd(III) chain. The authors showed that the clinical spectrum in their families with AAA extended from isolated AAA to classical Ehlers-Danlos type IV disease (with prominent cutaneous findings). More interestingly they showed that Ehlers-Danlos type IV and isolated AAA were observed in families with type III procollagen mutations, suggesting that a collagen defect could account for a fraction of AAA, although no precise estimation of this fraction can be given at this time. This finding also gives additional support to the observations of Menashi et al.zs on low content of type III collagen in a group of patients with familial AAA. In the two families described by Konmsaari et al.,26 the mutation behaved as a dominant trait. This finding appears in contradiction with Majumder et al.'s 9 conclusion on the recessivity of AAA but rein- forces our own observations (although we have not proved that our cases of AAA have an abnormality of collagen type III).
AAA is a complex disease, and we cannot expect to find a single physiopathologic explanation for all cases. Our data at least suggest that a genetic factor could be of major importance in the onset of AAA. This factor has been shown to be an alteration of one of the collagen III genes in some families. Whether the major gene effect always results from one abnormal collagen gcne or more likely from several dominant genes is still to be demonstrated. Further investigation on selected large families with AAA appears warranted.
AAA is a complex disorder with probably multiple pathogenetic pathways. In this article we presented a familial study of 313 AAA pedigrees selected without the use of systematic screening. Our series illustrates the importance of familial factors in AAA and raises the hypothesis, sustained by a familial genetic analysis, that AAA could be a mainly genetic disease. The major determinant factor in the appearance of AAA could be an inborn defect possibly of collagen type III or of other components of the connective tissue matrix. This defect behaves as a dominant trait with low age-dependent penetrance. Differences in the severity of the complications of AAA between familial and sporadic cases dearly appear. These differences could be related to the variable penetrance of individual mutations.
Systematic screening of AAA is an emerging issue. A common question is whether to apply AAA screening to a general population or to an "at risk" subgroup. We strongly recommend ultrasound screening of first-degree relatives aged 50 years and older, a method that now permits simple, noninvasive, and accurate detection and follow-up of AAA. Recently in our retrospective study of the determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms, we found 12% of rupture in aneurysms smaller than 44 mm and 22% when the diameter exceeded 50 mmS When the higher incidence of rupture in patients with positive family history and the risk of rupture even for small AAA (less than 50 mm) are considered, a more aggressive therapeutic attitude is mandatory. Ratio-nale for a national screening program has been recently given by Law et al.,4 who recommended one ultrasonography detection in men aged 60 years and older. As long as cost-effectiveness of those general policies has not been demonstrated, a reduced screening policy could be recommended at least for patients with other peripheral artery aneurysms and for first-degree relatives of patients with an AAA.
